FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Find Approved Dermatology Drugs in Clinical Development in FRANCE

A collaboration with SCORR Marketing

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Lidocaine,Hyaluronic Acid

            Therapeutic Area: Dermatology

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Crescita Therapeutics

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Distribution Agreement January 20, 2020

            Details:

            The partnership with FILLMED will allow Crescita to expand its product offering in the medical aesthetic field with the addition of the hyaluronic acid ART-Filler® injectables range and NCTF® 135 HA.